Associations of serum 25-hydroxyvitamin D and vitamin D receptor polymorphisms with risks of cardiovascular disease and mortality among patients with chronic kidney disease: a prospective study

被引:3
作者
Zhao, Shiyu [1 ,2 ]
Chen, Xue [1 ,2 ]
Wan, Zhenzhen [1 ,2 ]
Geng, Tingting [1 ,2 ]
Lu, Qi [1 ,2 ]
Yu, Hancheng [1 ,2 ]
Lin, Xiaoyu [1 ,2 ]
Pan, An [3 ]
Liu, Gang [1 ,2 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Nutr & Food Hyg,Hubei Key Lab Food Nutr & Saf, Wuhan, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, State Key Lab Environm Hlth Incubating, Wuhan, Peoples R China
[3] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Publ Hlth, Dept Epidemiol & Biostat,Minist Educ,Key Lab Envir, Wuhan, Peoples R China
基金
中国国家自然科学基金;
关键词
vitamin D; cardiovascular disease; chronic kidney disease; vitamin D receptor; prospective study; GENE POLYMORPHISMS; METAANALYSIS; DEFICIENCY;
D O I
10.1016/j.ajcnut.2024.04.001
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: Evidence regarding the relationships of serum 25-hydroxyvitamin D [25(OH)D] with cardiovascular diseases (CVD) and mortality among patients with chronic kidney disease (CKD) is limited and inconsistent. Objectives: This study aimed to investigate the associations between serum 25(OH)D and CVD incidence and mortality among patients with CKD. Methods: This prospective study included 21,507 participants with CKD and free of CVD in the UK Biobank. Incidences of total and subtypes of CVD and mortality were ascertained via electronic health records. Cox proportional hazard regression models were used to estimate the hazard ratios (HRs) and 95% confidential intervals (CIs) for CVD incidence and mortality. Results: The median serum 25(OH)D concentration was 44.0 nmol/L (interquartile range: 30.1, 60.6 nmol/L). After multivariable adjustment, compared with CKD patients with serum 25(OH)D concentrations of < 25 nmol/L, those with serum 25(OH)D >= 75 nmol/L had HRs (95% CIs) of 0.80 (0.71, 0.90) for total CVD incidence, 0.82 (0.69, 0.97) for ischemic heart disease, 0.56 (0.41, 0.77) for stroke, 0.64 (0.46, 0.88) for myocardial infarction, 0.62 (0.49, 0.80) for heart failure, 0.60 (0.43, 0.85) for CVD mortality, and 0.62 (0.52, 0.74) for all-cause mortality. In addition, these associations were not modified by vitamin D receptor polymorphisms, with no significant interaction detected. Conclusions: Higher serum 25(OH)D concentrations were significantly associated with lower risks of total and subtypes of CVD incidence and mortality among individuals with CKD. These fi ndings highlight the importance of maintaining adequate vitamin D status in the prevention of CVD and mortality in patients with CKD.
引用
收藏
页码:1397 / 1404
页数:8
相关论文
共 50 条
[21]   Effect of ergocalciferol supplementation on serum parathyroid hormone and serum 25-hydroxyvitamin D in chronic kidney disease [J].
DeVille, Jason ;
Thorp, Micah L. ;
Tobin, Lois ;
Gray, Eeva ;
Johnson, Eric S. ;
Smith, David H. .
NEPHROLOGY, 2006, 11 (06) :555-559
[22]   Low serum 25-hydroxyvitamin D levels are associated with increased cardiovascular morbidity and mortality [J].
Luo, Wei ;
Xu, Dan ;
Zhang, Jin ;
Zhou, Yao ;
Yang, Qin ;
Lv, Qiuju ;
Qu, Zhen .
POSTGRADUATE MEDICINE, 2023, 135 (02) :93-101
[23]   Vitamin D receptor BsmI polymorphism modulates soy intake and 25-hydroxyvitamin D supplementation benefits in cardiovascular disease risk factors profile [J].
Serrano, Jose C. E. ;
De Lorenzo, David ;
Cassanye, Anna ;
Martin-Gari, Meritxell ;
Espinel, Alberto ;
Antonio Delgado, Marco ;
Pamplona, Reinald ;
Portero-Otin, Manuel .
GENES AND NUTRITION, 2013, 8 (06) :561-569
[24]   The role of BsmI and FokI vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D in Brazilian patients with systemic lupus erythematosus [J].
Monticielo, O. A. ;
Brenol, J. C. T. ;
Chies, J. A. B. ;
Longo, M. G. F. ;
Rucatti, G. G. ;
Scalco, R. ;
Xavier, R. M. .
LUPUS, 2012, 21 (01) :43-52
[25]   Prospective Study of Serum 25-Hydroxyvitamin D Concentration and Mortality in a Chinese Population [J].
Lin, Shih-Wen ;
Chen, Wen ;
Fan, Jin-Hu ;
Dawsey, Sanford M. ;
Taylor, Philip R. ;
Qiao, You-Lin ;
Abnet, Christian C. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2012, 176 (11) :1043-1050
[26]   Association of Serum 25-Hydroxyvitamin D Concentrations With All-Cause and Cause-Specific Mortality Among Adult Patients With Existing Cardiovascular Disease [J].
Dai, Lei ;
Liu, Man ;
Chen, Liangkai .
FRONTIERS IN NUTRITION, 2021, 8
[27]   Insights on Vitamin D's Role in Cardiovascular Disease: Investigating the Association of 25-Hydroxyvitamin D with the Dimethylated Arginines [J].
Abu el Maaty, Mohamed A. ;
Hassanein, Sally I. ;
Hanafi, Rasha S. ;
Gad, Mohamed Z. .
JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY, 2013, 59 (03) :172-177
[28]   Association of serum 25-hydroxyvitamin D concentrations with all-cause mortality among individuals with kidney stone disease: the NHANES database prospective cohort study [J].
Gao, Meng ;
Liu, Minghui ;
Chen, Jinbo ;
Zhu, Zewu ;
Chen, Hequn .
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[29]   Serum 25-Hydroxyvitamin D, Vitamin D Receptor, and Vitamin-D-Binding Protein Gene Polymorphisms and Risk of Dementia Among Older Adults With Prediabetes [J].
Zhou, Chun ;
Gan, Xiaoqin ;
Ye, Ziliang ;
Zhang, Yanjun ;
Yang, Sisi ;
He, Panpan ;
Zhang, Yuanyuan ;
Liu, Mengyi ;
Wu, Qimeng ;
Qin, Xianhui .
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2024, 79 (04)
[30]   Serum 25-hydroxyvitamin D and the risk of cardiovascular disease: dose-response meta-analysis of prospective studies [J].
Zhang, Runhua ;
Li, Bohong ;
Gao, Xiang ;
Tian, Rui ;
Pan, Yuesong ;
Jiang, Yong ;
Gu, Hongqiu ;
Wang, Yilong ;
Wang, Yongjun ;
Liu, Gaifen .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2017, 105 (04) :810-819